Melagen Labs
PrivateLast Round
Grant
Apr 10, 2026
Total Funding Raised
$5.12M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Melagen Labs operates in Frontier & Industrial Tech and is based in New York City, New York. Its latest recorded funding round was a Grant round in April 2026.
Melagen Labs is an aerospace and defense company that develops radiation shielding technologies and materials for space applications.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Space Technology, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melagen Labs Comparables
Compare Melagen Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cosmic Shielding Corporation | 89% | |
| Artemis Shielding | 65% | |
| EmTDLab | 64% |
For institutional investors. Book with your work email.
Melagen Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 10, 2026 | ||||
| Accelerator | Jul 16, 2025 | ||||
| Accelerator | Sep 16, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Melagen Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| E2MC Ventures | Accelerator |
| JPMorgan Chase & Co. | Accelerator |
| Stellar Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$4.5M grant received
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asNov 3, 2026
On Nov 3rd '26, the 2026 Global Space Awards name Melagen Labs founder and CEO Muhammad Hunain one of five finalists for Playmaker of the Year for his work protecting space hardware from cosmic radiation.
- attends_eventNov 3, 2026
Melagen Labs founder and CEO Muhammad Hunain is a finalist for Playmaker of the Year at the 2026 Global Space Awards for protecting space hardware from cosmic radiation, with winners scheduled to be announced on Dec 11th '26 in the United Kingdom.
- expands_facilitiesOct 13, 2026
Melagen Labs launches a dedicated test facility in Texas that lets startups validate radiation-resilient payload prototypes.
For institutional investors. Book with your work email.
Melagen Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Melagen Labs's valuation, stock price, and market status.
Is Melagen Labs a public or private company?
Melagen Labs is a private company.
What is the current stock price of Melagen Labs?
Melagen Labs is a private company, so its shares have no public market price. Caplight tracks Melagen Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Melagen Labs worth (valuation)?
Valuation information for Melagen Labs is not publicly available.
Can I buy Melagen Labs stock?
Melagen Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Melagen Labs's last funding round?
Melagen Labs's most recent funding round was Grant on April 10, 2026.
Who are the main investors in Melagen Labs?
Key investors in Melagen Labs include Techstars.
Will Melagen Labs IPO soon?
No public IPO plans have been announced for Melagen Labs.
How can I track Melagen Labs secondary market activity?
Caplight tracks bids, offers, and trades in Melagen Labs's shares on secondary markets.